Skip to content
OpenCapital
Get started

HCW Biologics HCWB Q4 2025 Annual earnings

Reported March 31, 2026 · Before market open

Revenue$5.4MMiss by $1.6M
EPS-$2.63Miss by $1.79
Revenue estimate$7.0M
EPS estimate-$0.84

Next report

Aug 7, 2026 (In 1 week)
Revenue estimate$5.7M
EPS estimate-$1.98

Versus estimates

Revenue

Q1 2026$6.5MMiss by $11.1K
Q4 2025$5.4MMiss by $1.6M
Q3 2025$15.6KMiss by $7.0MQ2 2025$6.6KMiss by $450.0Q1 2025$5.1KQ4 2024$394.8KMiss by $6.6M

Diluted EPS

Q1 2026$0.37Beat by $0.81
Q4 2025-$2.63Miss by $1.79
Q3 2025-$2.02Miss by $3.60Q2 2025-$6.79Miss by $8.59Q1 2025-$0.05Q4 2024-$3.20Miss by $6.80

Ask the moment HCW Biologics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did HCW Biologics report Q4 2025 earnings?
HCW Biologics (HCWB) reported Q4 2025 earnings on March 31, 2026 before market open.
What were HCW Biologics's Q4 2025 revenue and EPS?
HCW Biologics reported revenue of $5.4M and eps of $-2.63 for Q4 2025.
Did HCW Biologics beat estimates in Q4 2025?
Revenue missed the consensus estimate of $7.0M by $1.6M. EPS missed the consensus estimate of $-0.84 by $1.79.
How did HCW Biologics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1268.0% from $394.8K a year earlier and eps grew 17.8% from $-3.20.
Where can I find HCW Biologics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-134936) and the 10-K periodic report (0001193125-26-134934) directly on SEC EDGAR. The filing index links above go to sec.gov.